Abstract
The generation of hexon-modified adenovirus vector has proven difficult. In this paper, we developed a novel method for rapid generation of hexon-modified adenoviral vector via one step ligation in vitro followed by quick white/blue color screening. The new system has the following features. First, eGFP expression driven by the CMV promoter in E1 region functions as a reporter to evaluate the tropism of hexon-modified adenovirus in vitro. Second, it has two unique restriction enzyme sites with sticky ends located in the hexon HVR5 region. Third, a lacZ expression cassette under the control of plac promoter is placed between the two restriction enzyme sites, which allows recombinants to be selected using blue/white screening. To prove the principle of the method, genetically modified adenoviruses were successfully produced by insertion of NGR, RGD or Tat PTD peptide into hexon HVR5. Furthermore, the transduction efficiency of the Tat PTD modified virus was shown to be a significant enhancement in A172 and CHO-K1 cells. In conclusion, the novel system makes the production of truly retargeted vectors more promising, which would be of substantial benefit for cancer gene therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 373-378 |
Number of pages | 6 |
Journal | Journal of Biotechnology |
Volume | 157 |
Issue number | 3 |
DOIs | |
State | Published - Feb 10 2012 |
Funding
This work was supported by the research grants to H.X. from National Natural Science Foundation of China (No. 30872993 and No. 31070137 ).
Keywords
- Adenoviral vector
- Directional cloning
- Gene therapy
- Hexon modification
- Quick screening
ASJC Scopus subject areas
- Applied Microbiology and Biotechnology
- Bioengineering
- Biotechnology